Nora Frey

Nora Frey is a Venture Partner at Seventure Partners based in Basel, Switzerland. She brings over 20 years of professional experience in healthcare research, investment management, and business development, having started her financial career in 1998 as a partner on the BB Biotech team at Bellevue Group. Frey subsequently founded Adamant Biomedical Investments AG, where she served as Chief Investment Officer, and co-founded both Cederberg GmbH and Giblot Food and Health GmbH. She holds a Doctor of Philosophy in Biochemistry and Immunology alongside a Master of Science degree in Microbiology from the University of Basel. Before assuming her current venture role in June 2021, she spent two years as an advisor for food and nutrition at Seventure Partners. Her current investment focus centers on scaling biotechnology, nutraceuticals, and microbiome-related opportunities within the broader food production and foodtech sectors.